Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Just 13% of men who opted for active surveillance over treatment adhered to the recommended monitoring schedule.
A conversation with NCI’s Howard Parnes, MD
How a baseball broadcaster brought his career and advocacy together to educate men about early detection of prostate cancer
Just for grins and giggles, I asked her the $64,000 question: How do you define biochemical recurrence?
Both new cases and mortality have declined or stabilized in most countries.
If you’re not going to acknowledge reader comments, why bother giving us the option to do comment in the first place?
I can’t wait to hear what the urologist has to say about this on 18 April.
I should have the results of my next PSA test by Friday.
Every doctor has his or her own take on the situation and what should be done, and very few of those opinions match.
Salvage radiation therapy is now higher on my list of options to consider, but I’m still concerned about potential long-term side effects.
I’ve got some serious thinking to do in the weeks ahead.
Rubraca shrank tumors and lowered PSA levels in men with advanced prostate cancer.
Screening rates for breast, cervical, colorectal and prostate cancer are still below public health targets.
It was pretty clear right from the start that he was of the “continue to monitor; no need to act right away” mindset.
I only met with the doctor once, but I’m confident he would have argued more forcefully if he thought I needed radiation therapy right away.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.